Prostate Cancer (PCa) is still ranked as the first cancer in the male population and evidences have suggested an alteration of glycemic and lipidic metabolism that are related to its progression and prognosis. The aim of the study is to investigate associations between enzymes’ expression, especially involved in the lipidic pathway, and PCa aggressiveness. We retrospectively analyzed data from 390 patients with PCa or benign prostatic hyperplasia (BPH) at the Department of Urology, University of Catania. Immunohistochemical slides were evaluated for the expression of proteins related to glucose and lipidic metabolism. A total of 286 were affected by PCa while 104 by BPH. We demonstrated that ATP-lyase (odds ratio [OR]: 1.71; p p p p = 0.049...
The human prostate gland is an endocrine organ where dysregulation of various hormonal factors may p...
INTRODUCTION: An altered metabolic regulation is involved in the development and progression of diff...
Prostate cancer (PCa) is the most common male cancer and the second leading cause of cancer death in...
Prostate cancer (PCa) is the common cause of death in men. The pathophysiological factors contributi...
Cancer is increasingly recognized as an extraordinarily heterogeneous disease featuring an intricate...
BACKGROUND/AIM: The connection between prostate cancer and inflammation has been proposed many years...
Background: Understanding the biologic mechanisms underlying the development of lethal prostate canc...
Prostate cancer (PCa) is a heterogeneous disease with regard to molecular alterations and clinical c...
Most cancer cells exhibit elevated levels of glycolysis and this metabolic pathway seems to be rela...
It was 80 years after the Otto Warburg discovery of aerobic glycolysis, a major hallmark in the unde...
Prostate cancer (PCa) remains the third most common type of cancer in men worldwide in 2021. Despite...
There is substantial evidence implicating environmental factors in the progression of prostate cance...
Prostate cancer (PCa) is a global health problem that affects millions of men every year. In the pas...
Cancer cells often depend on altered metabolism compared with their normal counterparts. [1],[2],[3]...
The human prostate gland is an endocrine organ where dysregulation of various hormonal factors may p...
The human prostate gland is an endocrine organ where dysregulation of various hormonal factors may p...
INTRODUCTION: An altered metabolic regulation is involved in the development and progression of diff...
Prostate cancer (PCa) is the most common male cancer and the second leading cause of cancer death in...
Prostate cancer (PCa) is the common cause of death in men. The pathophysiological factors contributi...
Cancer is increasingly recognized as an extraordinarily heterogeneous disease featuring an intricate...
BACKGROUND/AIM: The connection between prostate cancer and inflammation has been proposed many years...
Background: Understanding the biologic mechanisms underlying the development of lethal prostate canc...
Prostate cancer (PCa) is a heterogeneous disease with regard to molecular alterations and clinical c...
Most cancer cells exhibit elevated levels of glycolysis and this metabolic pathway seems to be rela...
It was 80 years after the Otto Warburg discovery of aerobic glycolysis, a major hallmark in the unde...
Prostate cancer (PCa) remains the third most common type of cancer in men worldwide in 2021. Despite...
There is substantial evidence implicating environmental factors in the progression of prostate cance...
Prostate cancer (PCa) is a global health problem that affects millions of men every year. In the pas...
Cancer cells often depend on altered metabolism compared with their normal counterparts. [1],[2],[3]...
The human prostate gland is an endocrine organ where dysregulation of various hormonal factors may p...
The human prostate gland is an endocrine organ where dysregulation of various hormonal factors may p...
INTRODUCTION: An altered metabolic regulation is involved in the development and progression of diff...
Prostate cancer (PCa) is the most common male cancer and the second leading cause of cancer death in...